The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2014Reduced Habitual Intrusions: An Early Marker of Parkinson's Disease?
Study Rationale:
Parkinson's disease is characterized by the loss of a neurotransmitter called dopamine in a part of the brain called the basal ganglia. Parts of this region are... -
PD Subtypes, 2007Prediction of Death, Dementia, Disability, Depression from the Time Course of UPDRS Motor Status
Parkinson’s disease is progressive. Early on, its effects are relatively minor, affecting mainly movement and causing shaking of the limbs. Later on, serious events -- early death, dementia...
-
Prescott Family Initiative at the Arizona Parkinson's Diseas, 2009Arizona Parkinson's Disease Consortium: Predictors of Parkinson’s Disease and Parkinson’s Disease-Dementia
Promising Outcomes of Original Grant:
The goals of the original grant were to expand the number of PD patients enrolled, incorporate new questionnaires for recording non-motor manifestations of PD... -
Rapid Response Innovation Awards, 2014Mirtazapine as a Treatment for Pathological Gambling
Objective/Rationale:
Pramipexole (Mirapex®) is a drug that is effective at alleviating movement deficits associated with Parkinson’s disease. However, pramipexole can induce compulsive... -
Research Grant, 2022Expanding Genetic Analyses in Parkinson’s Disease
Study Rationale: There is a critical need for greater understanding of the genetic component of Parkinson’s disease, both to predict and diagnose disease, but also to inform drug development efforts...
-
Prescott Family Initiative at the Arizona Parkinson's Diseas, 2006The Prescott Family Initiative at The Arizona Parkinson's Disease Consortium
Parkinson's disease is currently diagnosed clinically by finding slowness of movement along with either rest tremor or rigidity. However, the only way to definitively diagnose PD is by autopsy. In...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.